SCHEMBL7071079

SCHEMBL7071079

CCC(O)C/C=C/c1cncc(OC)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.50
MAP4K4 O95819 2/20 0.50
PRKACA P17612 2/20 0.50
ROCK1 Q13464 2/20 0.50
DYRK1A Q13627 2/20 0.50
PKN2 Q16513 2/20 0.50
CLK4 Q9HAZ1 2/20 0.50
MKNK2 Q9HBH9 2/20 0.50
STK17A Q9UEE5 2/20 0.50
NTRK3 Q16288 1/20 0.50
CHRNB2 P17787 2/20 0.48
CHRNA4 P43681 2/20 0.48
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA7 P36544 1/20 0.43
AKT1 P31749 4/20 0.35
GRIK1 P39086 1/20 0.35
GRIK2 Q13002 1/20 0.35
AURKA O14965 1/20 0.34
ERBB2 P04626 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7071081 1.00 ROCK2 (0.50) ROCK2MAP4K4PRKACAROCK1DYRK1A
SCHEMBL3017873 0.85 CHRNB2 (0.53) ROCK2MAP4K4PRKACAROCK1DYRK1A
SCHEMBL3017868 0.85 CHRNB2 (0.53) ROCK2MAP4K4PRKACAROCK1DYRK1A
SCHEMBL5197485 0.84 ROCK2 (0.40) ROCK2MAP4K4PRKACAROCK1DYRK1A
SCHEMBL5197491 0.84 ROCK2 (0.40) ROCK2MAP4K4PRKACAROCK1DYRK1A
SCHEMBL365733 0.83 ROCK2 (0.50) ROCK2MAP4K4PRKACAROCK1DYRK1A
SCHEMBL3960211 0.83 ROCK2 (0.50) ROCK2MAP4K4PRKACAROCK1DYRK1A
SCHEMBL3838406 0.79 CHRNB2 (0.53) ROCK2MAP4K4PRKACAROCK1DYRK1A
Phosphoric Acid SCHEMBL3956343 0.79 ROCK2 (0.44) ROCK2MAP4K4PRKACAROCK1DYRK1A
SCHEMBL621495 0.77 CHRNB2 (0.78) ROCK2MAP4K4PRKACAROCK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317267-A2 COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE Targacept, Inc. (US) 2003-06-11 EP disclosed
EP-1311265-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS Targacept, Inc. (US) 2003-05-21 EP disclosed
EP-1185514-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE Targacept, Inc. (US) 2002-03-13 EP disclosed
WO-2002005801-A2 COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE TARGACEPT, INC. (US) 2002-01-24 WO disclosed
WO-2002005798-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS TARGACEPT, INC. (US) 2002-01-24 WO disclosed
WO-2000075110-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE TARGACEPT, INC. (US) 2000-12-14 WO disclosed